The game changing DTP Combination Vaccine evolution to improve VCR

Speciality: Pediatrics

Description:

A warm welcome to all the medical professionals in this interesting session on The game changing DTP Combination Vaccine evolution to improve VCR
The DTP combination vaccine, which protects against diphtheria, tetanus, and pertussis, has undergone significant evolution over the years, becoming a game-changer in global immunization efforts. The original whole-cell pertussis vaccine (DTPw), while effective, was associated with higher rates of side effects such as fever and injection site reactions. This led to the development of the acellular pertussis vaccine (DTPa), which contains purified components of the pertussis bacterium, resulting in fewer side effects and improved acceptance among parents and healthcare providers.
The evolution of the DTP vaccine has had a profound impact on Vaccine Coverage Rates (VCR). The shift from DTPw to DTPa, coupled with combination vaccines that include protection against additional diseases like Haemophilus influenzae type b (Hib) and hepatitis B, has streamlined immunization schedules and reduced the number of injections required. This convenience has improved VCR, particularly in countries where access to healthcare can be challenging. The introduction of hexavalent vaccines, which combine DTPa with vaccines for Hib, hepatitis B, and polio, represents the latest advancement, further simplifying immunization programs and enhancing global efforts to protect children against multiple life-threatening diseases.
Therefore, get an overall knowledge of the game changing DTP combination vaccine evolution to improve VCRSee More Webinars @ Hidoc Webinars